Serial 79413512
Dead / Abandoned — International registration dead — extension of protection cancelled (as of 05 Sept 2025)
What this means for you
This application is over — abandoned 05 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79413512
- Mark type
- Design / logo
- Filed
- 09 Jul 2024
- Abandoned
- 05 Sept 2025
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical, medical and veterinary preparations; pharmaceutical, medical and veterinary preparations in the field of microbiome modulating therapeutics; pharmaceutical preparations for use in targeted pharmaceutical therapies; pharmaceutical preparations and products for the treatment of gastrointestinal disorders and diseases; biotechnological preparations for medical use; biological compounds for use in targeted pharmaceutical therapies; proteins with diagnostic and therapeutic uses; chemical and enzyme preparations for medical or veterinary purposes; reagents and substances for use in testing for medical and veterinary purposes; drug delivery agents that facilitate the delivery of pharmaceutical preparations; intestinal microbiome pharmaceutical preparations; nutritive agents for processing living cells for medical use; reagents for use in biological processing for medical purposes; solutions for medical use in the preservation of human excreta; preservatives for maintaining the viability of micro-organisms in cultures for medical purposes; probiotic bacterial formulations for medical use; clinical medical reagents; diagnostic and testing preparations for clinical, medical and medical laboratory use; diagnostic reagents and assay components for clinical, medical and medical laboratory use; enzymes for medical purposes; yeast for intracellular production of recombinant proteins; yeast for pharmaceutical purposes; dietary supplements; food supplements; topical gels for medical and therapeutic use; intestinal microbiome medicinal preparations; pharmaceuticals or therapeutic preparations in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; diagnostic preparations for use in the fields of microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; medical preparations for use in connection with intestinal microbiota transfer; chemical preparations and reagents for medical purposes; diagnostic biomarkers for in vitro and in vivo testing for medical use.
- Class 042 — Scientific and technological services: Research and development services in the fields of medicine and health; research and development in the pharmaceutical and biotechnology fields; biological, scientific, clinical and medical research and development; drug discovery services; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of compounds for use in targeted pharmaceutical therapies; medical and pharmacological research services; research relating to molecular sciences and biotechnology; research and development in the field of microorganisms and cells; research and development in the field of therapeutics; scientific and medical research services in the field of microbiome modulating therapeutics; research and development of pharmaceutical preparations for the treatment of gastrointestinal disorders and diseases; research and development of biological drug delivery platforms; biochemical research and analysis; bacteriological research and analysis; analysis in the field of intestinal microbiology; analysis of human excreta for medical research; microbiological testing; biological analysis; research, development, analysis and evaluation services in connection with biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences, bacteria, physiology, biology, genetics, genomics, microbiome, metabolomics, proteomics, glycomics, biochemistry, probiotics, prebiotics, nutraceutical supplements, health, wellness, physical well-being, mental well-being, exercise, weight planning, weight management, diet, nutrition and/or sleep; research, development, analysis and evaluation services in connection with microbiology, genetics, the human immune system, the human gut microbiome or gastrointestinal health; DNA screening for scientific research purposes; testing of pharmaceuticals; testing, authentication and quality control; biotechnology and chemical testing; development of biochemical reagents; laboratory services; clinical research; clinical trials; conducting early evaluations in the field of new pharmaceuticals; research and development for use in clinical trials; providing information about the results of clinical trials for pharmaceutical products; diagnostic and testing services; structural and functional analysis of genomes; services for assessing the efficiency of medical and veterinary drugs; veterinary research and development services; product design and development; design services relating to the biotechnology industry; analysis of product development; pharmaceutical product evaluation; preparation of reports in the field of biotechnology and/or gut health; scientific research and analysis; scientific research project management; scientific risk assessment; industrial analysis and research; analysis of product design; technical data analysis; consultancy, information and advisory services relating to all of the aforesaid services.
Owner
Prosecution history
- 19 Sept 2025 — DEATH OF INTERNATIONAL REGISTRATION
- 17 Sept 2025 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 17 Sept 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 22 Mar 2025 — REFUSAL PROCESSED BY IB
- 04 Mar 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 04 Mar 2025 — REFUSAL PROCESSED BY MPU
- 14 Feb 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 15 Jan 2025 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 14 Jan 2025 — NON-FINAL ACTION WRITTEN
- 06 Jan 2025 — ASSIGNED TO EXAMINER
- 03 Jan 2025 — APPLICATION FILING RECEIPT MAILED
- 03 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Jan 2025 — SN ASSIGNED FOR SECT 66A APPL FROM IB